Tempus AI, Inc. (NASDAQ:TEM) emerges as one of the top 11 IPOs in the last 2 years. Stock price target raised post strong Q2 earnings and FDA approval for Tempus Pixel, boosting growth prospects. H.C. Wainwright increases price target to $98, indicating potential upside for the stock. Company founded in 2015, based in Illinois, leads in AI application for precision medicine.

Read more at Yahoo Finance: Tempus AI Surges Since IPO as FDA Clearance Boosts Growth Outlook